We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+11.08%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$134B
AUM Growth
+$14.8B
Cap. Flow
+$2.42B
Cap. Flow %
1.81%
Top 10 Hldgs %
25.29%
Holding
4,017
New
232
Increased
1,652
Reduced
1,816
Closed
191

Sector Composition

Rank Sector Weight
1 Technology 15.71%
2 Financials 9.02%
3 Healthcare 7.82%
4 Industrials 6.8%
5 Consumer Discretionary 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPAY icon
851
Corpay
CPAY
$26.7B
$15.5M 0.01%
54,937
-17,563
-24% -$4.36M
MTB icon
852
M&T Bank
MTB
$36.4B
$15.5M 0.01%
113,176
-3,035
-3% -$381K
MRNA icon
853
Moderna
MRNA
$24.2B
$15.4M 0.01%
154,442
-31,900
-17% -$2.68M
PSLV icon
854
Sprott Physical Silver Trust
PSLV
$13.5B
$15.4M 0.01%
1,900,816
+1,206,770
+174% +$9.53M
ES icon
855
Eversource Energy
ES
$26.8B
$15.3M 0.01%
248,504
-15,500
-6% -$894K
KRP icon
856
Kimbell Royalty Partners
KRP
$1.5B
$15.3M 0.01%
1,018,789
-14,243
-1% -$223K
HLN icon
857
Haleon
HLN
$43.7B
$15.3M 0.01%
1,862,612
+3,941
+0.2% +$32.5K
ZBH icon
858
Zimmer Biomet
ZBH
$18.5B
$15.3M 0.01%
125,893
-93,401
-43% -$10.4M
BBCA icon
859
JPMorgan BetaBuilders Canada ETF
BBCA
$11.3B
$15.3M 0.01%
238,143
-10,968
-4% -$650K
CNS icon
860
Cohen & Steers
CNS
$4.34B
$15.2M 0.01%
200,944
+56,153
+39% +$3.38M
DKNG icon
861
DraftKings
DKNG
$12.6B
$15.2M 0.01%
431,385
+56,674
+15% +$1.9M
WEX icon
862
WEX
WEX
$6.44B
$15.2M 0.01%
77,985
-1,458
-2% -$264K
OEF icon
863
iShares S&P 100 ETF
OEF
$20.4B
$15.2M 0.01%
67,868
+5,407
+9% +$1.14M
ENR icon
864
Energizer
ENR
$1.53B
$15.1M 0.01%
475,781
-25,920
-5% -$821K
ARCC icon
865
Ares Capital
ARCC
$14.3B
$15M 0.01%
749,880
+11,266
+2% +$220K
BERY
866
DELISTED
Berry Global Group, Inc.
BERY
$14.9M 0.01%
241,304
+22,240
+10% +$1.25M
JLL icon
867
Jones Lang LaSalle
JLL
$16.7B
$14.9M 0.01%
78,987
-478
-0.6% -$72.3K
IVOO icon
868
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.92B
$14.9M 0.01%
158,596
+587
+0.4% +$50.5K
RCL icon
869
Royal Caribbean
RCL
$82.1B
$14.9M 0.01%
115,034
+37,784
+49% +$3.85M
NUV icon
870
Nuveen Municipal Value Fund
NUV
$1.9B
$14.9M 0.01%
1,730,131
-868,726
-33% -$7.23M
CPB icon
871
Campbell Soup
CPB
$6.78B
$14.9M 0.01%
343,846
-22,120
-6% -$910K
CTRE icon
872
CareTrust REIT
CTRE
$9.14B
$14.9M 0.01%
663,887
+91,670
+16% +$2.03M
ON icon
873
ON Semiconductor
ON
$31.6B
$14.8M 0.01%
177,557
-163,782
-48% -$12.9M
PICK icon
874
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.33B
$14.8M 0.01%
343,253
-925
-0.3% -$36.8K
MUSA icon
875
Murphy USA
MUSA
$10B
$14.7M 0.01%
41,320
-210
-0.5% -$76.1K

Similar funds

Raymond James & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Raymond James & Associates held 4,017 positions worth $134B, up 12% from $119B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q4 2023 filing shows 232 new, 1,652 increased, 1,816 reduced and 191 closed positions. Its largest new stake was Delek US: 515,324 shares worth $13.3M. The largest sale was Pioneer Natural Resource Co., an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2023 buy was Delek US: 515,324 shares worth $13.3M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $219M increase.
  • Raymond James & Associates's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $124M.
  • Raymond James & Associates fully exited Kayne Anderson NextGen Energy & Infrastructure, Inc. in Q4 2023, selling an estimated $22.8M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $134B portfolio in Q4 2023.
  • Raymond James & Associates opened 232 new positions and closed 191 in Q4 2023.
  • Raymond James & Associates's portfolio value rose 12% quarter-over-quarter to $134B.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.